NEULAND LABS share price has zoomed 5% and is presently trading at Rs 7,022.7.
Meanwhile, the BSE HEALTHCARE index is at 36,799.8 (up 0.2%).
Among the top gainers in the BSE HEALTHCARE index today are KIMS (up 4.3%) and DR. LAL PATHLABS (up 2.3%).
ASTER DM HEALTHCARE (down 3.0%) and POLY MEDICURE (down 1.9%) are among the top losers today.
Over the last one year, NEULAND LABS has moved up from Rs 2,869.8 to Rs 7,022.7, registering a gain of Rs 4,152.9 (up 144.7%).
On the other hand, the BSE HEALTHCARE index has moved up from 25,114.1 to 36,799.8, registering a gain of 46.5% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Natco Pharma (up 92.2%), Cadila Healthcare (up 91.9%) and Glenmark Pharma (up 90.1%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 77,598.0 (up 0.3%).
The top gainers among the BSE Sensex today are Ultratech Cement (up 1.7%) and HDFC Bank (up 1.1%). The most traded stocks in the BSE Sensex are ICICI Bank and HDFC Bank.
In the meantime, NSE Nifty is at 23,615.7 (up 0.3%). Ultratech Cement and Hindalco are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 63,523.2 to 77,598.0, registering a gain of 14,074.8 points (up 22.2%).
NEULAND LABS net profit fell 20.1% YoY to Rs 676 million for the quarter ended March 2024, compared to a profit of Rs 845 million a year ago. Net sales declined 5.4% to Rs 3,850 million during the period as against Rs 4,071 million in January-March 2023.
For the year ended March 2023, NEULAND LABS reported 156.2% increase in net profit to Rs 1,635 million compared to net profit of Rs 638 million during FY22. Revenue of the company grew 25.2% to Rs 11,912 million during FY23.
The current Price to earnings ratio of NEULAND LABS, based on rolling 12 month earnings, stands at 30.0.
Equitymaster requests your view! Post a comment on "NEULAND LABS Gains 5%; BSE HEALTHCARE Index Up 0.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!